Abnormal iron deposition associated with lipid peroxidation in transgenic mice expressing interleukin-6 in the brain

Journal of Neuropathology and Experimental Neurology

Volumn 57, Issue 3, 1998, Pages 268-282

  Castelnau, Pierre A ^a   Garrett, Robert S ^a   Palinski, Wulf ^b   Witztum, Joseph L ^b   Campbell, Iain L ^c   Powell, Henry C ^a,d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^c SCRIPPS RESEARCH INSTITUTE   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Blood brain barrier; Degeneration; Ferritin; Free radicals; Interleukin 6; Iron; Transferrin

Indexed keywords

FERRITIN; GLIAL FIBRILLARY ACIDIC PROTEIN; INTERLEUKIN 3; INTERLEUKIN 6; IRON; IRON BINDING PROTEIN; LIPOFUSCIN; MALONALDEHYDE; TRANSFERRIN RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATOMIC ABSORPTION SPECTROMETRY; BLOOD BRAIN BARRIER; CEREBELLUM; CONTROLLED STUDY; DEGENERATIVE DISEASE; IRON METABOLISM; IRON OVERLOAD; LIPID PEROXIDATION; MOUSE; NEOCORTEX; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; TRANSGENIC MOUSE; ULTRASTRUCTURE;

EID: 0031893710     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005072-199803000-00008     Document Type: Article

References (59)

1. Campbell I, Abraham CR, Masliah E, et al. Neurologic disease induced in transgenic mice by cerebral overexpression of interleukin 6. Proc Natl Acad Sci USA 1993;90:10061-65
2. Heyser CJ, Masliah E, Samimi A, Campbell I, Gold LH. Progressive decline in avoidance learning paralleled by inflammatory neurodegeneration in transgenic mice expressing interleukin-6 in the brain. Proc Natl Acad Sci USA 1997;94:1500-1505
3. Steffensen SC, Campbell IL, Henriksen SJ. Site-specific hippocampal pathophysiology due to cerebral overexpression of interleukin-6 in transgenic mice. Brain Res 1994;652:149-53
4. Chiang C-S, Stalder A, Samimi A, Campbell IL. Reactive gliosis as a consequence of interleukin-6 expression in the brain: Studies in transgenic mice. Dev Neurosci 1994;16:212-21
5. Brett FM, Mizisin AP, Powell HC, Campbell IL. Evolution of neuropathologic abnormalities associated with blood-brain barrier breakdown in transgenic mice expressing interleukin-6 in astrocytes. J Neuropathol Exp Neurol 1995;54:766-75
6. Castelnau PA, Campbell IL, Powell HC. Prion protein (PrP) is not involved in the pathogenesis of spongiform encephalopathy in transgenic mice expressing interleukin-6 in the brain. Neurosci Lett 1997;234:15-18
7. Aisen P. Entry of iron into cells: A new role for the transferrin receptor in modulating iron release from transferrin. Ann Neurol 1992;32:S62-S68
8. Gelman B. Iron in CNS disease. J Neuropathol Exp Neurol 1995; 54:477-86
9. Koeppen AH. The history of iron in the brain. J Neurol Sci 1995; 134S:1-9
10. Connor JR, Menzies SL. Relationship of iron to oligodendrocytes and myelination. Glia 1996;17:83-93
11. Brittenham GM. The red cell cycle, in iron metabolism in health and disease. In: Brock JH, Halliday JW, Pippard MJ, Powell LW, eds. London: Saunders Company Ltd, 1994:31-62
12. Weiss G, Wachter H, Fuchs D. Linkage of cell mediated immunity to iron metabolism. Immunol Today 1995;16:495-500
13. Bothwell TH, Charlton RW, Motulsky AG. Hemochromatosis. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The metabolic and molecular basis of inherited disease. New York: McGraw-Hill, 1995:2237-70
14. Gerlach M, Ben-Shachar D, Riederer P, Youdim MB. Altered brain metabolism of iron as a cause of neurodegenerative diseases? J Neurochem 1994;63:793-807
15. Yehuda S, Youdim MBH. Brain iron deficiency: Biochemistry and behavior. In: Youdim MBH, ed. Brain iron: Neurochemical and behavioural aspects. Philadelphia: Taylor & Francis, 1988:89-114
16. Olanow C, Arendash G. Metals and free radicals in neurodegeneration. Curr Opin Neurol 1994;7:548-58
17. Swaiman KF. Disorders of the basal ganglia. In: Swaiman KF, ed. Pediatric neurology - principles and practice. St Louis: Mosby, 1994:1071-98
18. Smith MA, Harris PLR, Sayre LM, Perry G. Iron accumulation in Alzheimer disease is a source of redox-generated free radicals. Proc Natl Acad Sci 1997;94:9866-68
19. Halliwell B, Gutteridge JMC. Lipid peroxidation: A radical chain reaction. In: Halliwell B, Gutteridge JMC, eds. Free radicals in biology and medicine. Oxford: Clarendon Press, 1989:188-266
20. Britton RS, Ramm GA, Olynyk J, Singh R, O'Neill R, Bacon BR. Pathophysiology of iron toxicity. In: Hershko C, Konijn AM, Aisen P, eds. Progress in iron research. New York: Plenum Press, 1994: 239-53
21. Evans PH. Free radicals in brain metabolism and pathology. In: Cheeseman KH, Slater TF, eds. Free radicals in medicine. London: Churchill Livingstone, 1993:577-87
22. Palinski W, Ylä-Herttuala S, Rosenfeld ME, et al. Antisera and monoclonal antibodies specific for epitopes generated during oxidative modification of low density lipoprotein. Arteriosclerosis 1990;10:325-35
23. Sohal RS, Brunk UT. Lipofuscin as an indicator of oxidative stress and aging. In: Porta E, ed. Lipofuscin and ceroid pigments. New York: Plenum Press, 1989:17-30
24. Roberts R, Sandra A, Siek GC, Lucas JJ, Fine RE. Studies of the mechanism of iron transport across the blood-brain-barrier. Ann Neurol 1992;32:S43-S50
25. Taylor EM, Crowe A, Morgan EH. Transferrin and iron uptake by the brain: Effects of altered iron status. J Neurochem 1991;57: 1584-92
26. Testa U, Pelosi E, Peschle C. The transferrin receptor. Crit Rev Oncogen 1993;4:241-76
27. Jefferies WA, Brandon MR, Hunt SV, Williams AF, Gatter KC, Mason DY. Transferrin receptor on endothelium of brain capillaries. Nature 1984;312:162-63
28. Hill JM, Switzer RC. The regional distribution and cellular localization of iron in the rat brain. Neuroscience 1984;11:595-603
29. Benkovic SA, Connor JR. Ferritin, transferrin, and iron in selected regions of the adult and aged rat brain. J Comp Neurol 1993;338: 97-113
30. Connor JR, Pavlick G, Karli D, Menzies SL, Palmer C. A histochemical study of iron-positive cells in the developing rat brain. J Comp Neurol 1995;355:111-23
31. Francois C, Nguyen-Legros J, Percheron G. Topographical and cytological localization of iron in rat and monkey brains. Brain Res 1981;215:317-22
32. Chiang C-S, Powell HC, Gold LH, Samimi A, Campbell IL. Macrophage/microglial-mediated primary demyelination and motor disease induced by the central nervous system production of interleukin-3 in transgenic mice. J Clin Invest 1996;97:1512-24
33. Nguyen-Legros J, Bizot J, Bolesse M, Pulicani J. "Noir de diaminobenzidine": Une nouvelle méthode histochimique de révélation du fer exogène. Histochemistry 1980;66:239-44
34. Floyd RA, Carney JM. Free radical damage to protein and DNA: Mechanisms involved and relevant observations on brain undergoing oxidative stress. Ann Neurol 1992;32:S22-S27
35. Gutteridge JMC. Iron and oxygen radicals in brain. Ann Neurol 1992;32:S16-S21
36. Koeppen A, Dickson A, Chu R, Thach R. The pathogenesis of superficial siderosis of the central nervous system. Ann Neurol 1993;34:646-53
37. Bartlett WP, Li X-S, Connor JR. Expression of transferrin mRNA in the CNS of normal and Jimpy mice. J Neurochem 1991;57:318-22
38. Roskams AJ, Connor JR. Transferrin receptor expression in myelin deficient (md) rats. J Neurosci Res 1992;31:421-27
39. Connor JR, Roskams AJ, Menzies SL, Williams ME. Transferrin in the central nervous system of the shiverer mouse myelin mutant. J Neurosci Res 1993;36:501-7
40. Dickinson TK, Devenyl AG, Connor JR. Distribution of injected iron 59 and manganese 54 in hypotransferrinemic mice. J Lab Clin Med 1996;128:270-78
41. Brock JH, Djeha A, Ismail M, Oria R, Sinclair RH. Cellular responses to iron and iron compounds. In: Hershko C, Konijn AM, Aisen P, eds. Progress in iron research. New York: Plenum Press, 1994:91-100
42. Tamm I, Cardinale I, Krueger J, Murphy JS, May LT, Seghal PB. Interleukin 6 decreases cell-cell association and increases motility of ductal breast carcinoma cells. J Exp Med 1989;170:1649-69
43. Duchini A, Govindarayan S, Santucci M, Zampi G, Hofman FM. Effects of tumor necrosis factor-alpha and interleukin-6 on fluid-phase permeability and ammonia diffusion in CNS-derived endothelial cells. J Investig Med 1996;44:474-82
44. Duchen LW. General pathology of neurons and neuroglia. In: Hume-Adams J, Duchen LW, eds. Greenfield's neuropathology. Oxford: Oxford University Press, 1992:1-68
45. Barron KD. The microglial cell. A historical review. J Neurol Sci 1995;134S:57-68
46. Kaplan J, Jordan I, Sturrock A. Regulation of the transferrin-independent iron transport system in cultured cells. J Biol Chem 1991;266:2997-3004
47. Rothenberger S, Food MR, Gabathuler R, et al. Coincident expression and distribution of melanotransferrin and transferrin receptor in human brain capillary endothelium. Brain Res 1996;712:117-21
48. Bradbury MW. The blood-brain barrier. Experimental physiology 1993;78:453-72
49. Kobune M, Kohgo Y, Kato J, Miyazaki E, Niitsu Y. Interleukin-6 enhances hepatic transferrin uptake and ferritin expression in rats. Hepatology 1994;19:1468-75
50. Rogers JT. Ferritin translation by interleukin-6: The role of sequences upstream of the start codons of the heavy and light subunit genes. Blood 1996;87:2525-37
51. Shingu M, Isayama T, Yasutake C, et al. Role of oxygen radicals and IL-6 in IL-1 dependent cartilage matrix degradation. Inflammation 1994;18:613-23
52. Sato M, Sasaki M, Hojo H. Antioxidative roles of metallothionein and manganese Superoxide dismutase induced by tumor necrosis factor-alpha and interleukin-6. Arch Biochem Biophys 1995;316: 738-44
53. Braughler JM, Duncan LA, Chase RL. The involvment of iron in lipid peroxidation. Importance of ferric to ferrous ratios in initiation. J Biol Chem 1986;261:10282-89
54. Subbarao KV, Richardson JS. Iron-dependent peroxidation of rat brain: A regional study. J Neurosci Res 1990;26:224-32
55. Houglum K, Filip M, Witztum JL, Chojkier M. Malondialdehyde and 4-Hydroxynonenal protein adducts in plasma and liver of rats with iron overload. J Clin Invest 1990;86:1991-98
56. Newcombe J, Li H, Cuzner M. Low density lipoprotein uptake by macrophages in multiple sclerosis plaques: Implications for pathogenesis. Neuropathol and Appl Neurobiol 1994;20:152-62
57. Sayre L, Zelasko D, Harris P, Salomon R, Perry G, Smith M. 4-hydroxynonenal-derived lipid peroxidation end products are increased in Alzheimer disease [abstract]. J Neuropathol Exp Neurol 1997;56:574
58. Bellinger FP, Madamba SG, Campbell IL, Siggins GR. Reduced long term potentiation in the dentate gyrus of transgenic mice with cerebral overexpression of interleukin-6. Neurosci Lett 1995;198: 95-98
59. Barnum SR, Jones JL, Muller-Ladner U, Samimi A, Campbell IL. Chronic complement C3 gene expression in the CNS of transgenic mice with astrocyte-targeted interleukin-6 expression. Glia 1996; 18:107-17